This inventor holds 2 USPTO granted patents. Top assignee: Piramal Life Sciences Limited. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Anagha Damre: Innovator in Pharmaceutical Chemistry
Introduction
Anagha Damre is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target tumor necrosis factor-alpha (TNF-α). Her innovative work has the potential to impact the treatment of various inflammatory disorders.
Latest Patents
Anagha Damre holds two patents that focus on fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha. These compounds are characterized by specific formulas where V is CH, W is S(O), and various other components are defined to enhance their efficacy. The compounds are designed to serve as medicaments for the treatment and prevention of disorders caused by increased TNF-α activity, particularly in the context of inflammation.
Career Highlights
Anagha is currently employed at Piramal Life Sciences Limited, where she continues to advance her research in pharmaceutical innovations. Her work is recognized for its potential to lead to new therapeutic options for patients suffering from inflammatory conditions.
Collaborations
Anagha collaborates with notable colleagues, including Bansi Lal and Somesh Sharma, to further her research and development efforts in the pharmaceutical sector.
Conclusion
Anagha Damre's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patents and ongoing work at Piramal Life Sciences Limited highlight her role as a key figure in the fight against inflammatory disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile